Literature DB >> 10088658

Monthly measurements of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in healthy prepubertal children: characterization and relationship with growth: the 1-year growth study.

L Gelander1, W F Blum, L Larsson, S Rosberg, K Albertsson-Wikland.   

Abstract

The usefulness of measurements of IGF-I or IGF-binding protein-3 (IGFBP-3) in the clinical management of growth disorders is dependent on the extent of physiologic variation in their concentrations. Our purpose was therefore to investigate the longitudinal intraindividual variation in serum concentration of IGF-I and IGFBP-3 in healthy prepubertal children. Monthly serum samples and auxologic measurements were taken over a period of 1 y from 65 prepubertal children (38 boys, 27 girls; mean age 9.1 y, range 7.8-10.8). Concentrations of IGF-I and IGFBP-3 were measured by RIA. The mean (+/-SD) serum concentration of IGF-I in the children was 165 +/- 42.0 microg/L, with a mean coefficient of variation (CV) of 13.9% around the annual mean serum concentration for each child. The corresponding mean concentration of IGFBP-3 was 3273 +/- 604.5 microg/L, and the mean CV for each child was 9.7%. These monthly longitudinal variations in IGF-I and IGFBP-3 were parallel to changes in longitudinal growth. Short-term changes (1 mo) in IGF-I were positively correlated with changes in weight (r(s) = 0.42, p < 0.0005) and body mass index (r(s) = 0.45, p < 0.0005), and negatively correlated with minor intercurrent illnesses (-0.32; p < 0.05). Seasonal fluctuations also occurred, with short term changes in IGF-I (1 mo) and IGFBP-3 (3 mo), increasing with increasing outdoor temperatures (r(s) = 0.30, p < 0.05 and r(s) = 0.39, p < 0.005, respectively). We conclude, that there are significant changes in both IGF-I and IGFBP-3 that occur in association with growth, and that IGF-I is more sensitive than IGFBP-3 to short-term changes in weight, body mass index, and intercurrent illnesses. Physiologic short-term changes must therefore be taken into consideration when using serum levels of IGF-I or IGFBP-3 in the evaluation of the short or slowly growing child.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10088658     DOI: 10.1203/00006450-199903000-00015

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Pharmacodynamic considerations with recombinant human insulin-like growth factor-I in children.

Authors:  Robert J Ferry; Pinchas Cohen; Lorraine E Levitt Katz
Journal:  Horm Res       Date:  2005-05-09

2.  Growth factors, adiponectin, leptin and body mass index in pre-pubertal children born large for gestational age.

Authors:  A S Challa; E N Evagelidou; V I Giapros; V I Cholevas; S K Andronikou
Journal:  J Endocrinol Invest       Date:  2010-06-28       Impact factor: 4.256

3.  Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies.

Authors:  Erica T Warner; Rong Hu; Laura C Collins; Andrew H Beck; Stuart Schnitt; Bernard Rosner; A Heather Eliassen; Karin B Michels; Walter C Willett; Rulla M Tamimi
Journal:  Cancer Prev Res (Phila)       Date:  2016-09

4.  The effect of different patterns of growth hormone administration on the IGF axis and somatic and skeletal growth of the dwarf rat.

Authors:  Melissa Westwood; Arfa R Maqsood; Mattea Solomon; Andrew J Whatmore; Julian R E Davis; Robert C Baxter; Evelien F Gevers; Iain C A F Robinson; Peter E Clayton
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-27       Impact factor: 4.310

5.  Insulin-like growth factor I correlates with lean body mass in cystic fibrosis patients.

Authors:  I Sermet-Gaudelus; J C Souberbielle; I Azhar; J C Ruiz; P Magnine; V Colomb; C Le Bihan; D Folio; G Lenoir
Journal:  Arch Dis Child       Date:  2003-11       Impact factor: 3.791

6.  Seasonal variations in growth and body composition of 8-11-y-old Danish children.

Authors:  Stine-Mathilde Dalskov; Christian Ritz; Anni Larnkjær; Camilla T Damsgaard; Rikke A Petersen; Louise B Sørensen; Mads F Hjorth; Ken K Ong; Arne Astrup; Christian Mølgaard; Kim F Michaelsen
Journal:  Pediatr Res       Date:  2015-10-21       Impact factor: 3.756

7.  Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.

Authors:  Elena Lundberg; Berit Kriström; Bjorn Jonsson; Kerstin Albertsson-Wikland
Journal:  BMC Endocr Disord       Date:  2015-12-18       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.